📊 Dow Jones (4H) Analysis
The Dow just broke through the 45,700 resistance and is now pulling back to retest that same level as support.
✅ Key points:
The 45,700 zone, which acted as resistance before, could flip into strong support now.
Fibonacci retracements (0.5 & 0.618) line up right in this area, adding more confluence.
The ascending trendline and moving average are also sitting below price, keeping the bullish structure intact.
🎯 Targets:
Short-term: 46,200 – 46,400
Medium-term (measured move from the ascending triangle): 47,000 – 47,200
⚠️ Invalidation:
If price loses the 45,500 – 45,600 zone, we could see a deeper correction back to 45,000 – 45,200.
---
📌 Summary:
As long as the pullback into 45,700 holds, the bullish scenario stays in play and higher targets remain on the table.
---
🔥 What do you think? Is this just a clean retest before a push to 47,200, or will the Dow drop back below support?
The Dow just broke through the 45,700 resistance and is now pulling back to retest that same level as support.
✅ Key points:
The 45,700 zone, which acted as resistance before, could flip into strong support now.
Fibonacci retracements (0.5 & 0.618) line up right in this area, adding more confluence.
The ascending trendline and moving average are also sitting below price, keeping the bullish structure intact.
🎯 Targets:
Short-term: 46,200 – 46,400
Medium-term (measured move from the ascending triangle): 47,000 – 47,200
⚠️ Invalidation:
If price loses the 45,500 – 45,600 zone, we could see a deeper correction back to 45,000 – 45,200.
---
📌 Summary:
As long as the pullback into 45,700 holds, the bullish scenario stays in play and higher targets remain on the table.
---
🔥 What do you think? Is this just a clean retest before a push to 47,200, or will the Dow drop back below support?
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.